Analysis of the results showed significant differences in the percentage of CD16+NKG2D+ cells in the PBMC+PC and the PBMC+G2 groups compared with the PBMC+IL2 group in CRC and normal PBMCs (Figure 2A). This evidence concerns the gene KLRK1 and colorectal carcinoma.